These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 37547759)

  • 1. Mini-organs with big impact: Organoids in liver cancer studies.
    Khawar MB; Wang Y; Majeed A; Afzal A; Haneef K; Sun H
    Oncol Res; 2023; 31(5):677-688. PubMed ID: 37547759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
    Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
    Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy.
    Chen L; Wei X; Gu D; Xu Y; Zhou H
    Cancer Lett; 2023 Feb; 555():216048. PubMed ID: 36603689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma.
    El-Derby AM; Khedr MA; Ghoneim NI; Gabr MM; Khater SM; El-Badri N
    J Transl Med; 2024 May; 22(1):487. PubMed ID: 38773585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.
    Nuciforo S; Fofana I; Matter MS; Blumer T; Calabrese D; Boldanova T; Piscuoglio S; Wieland S; Ringnalda F; Schwank G; Terracciano LM; Ng CKY; Heim MH
    Cell Rep; 2018 Jul; 24(5):1363-1376. PubMed ID: 30067989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
    Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoids as research models for hepatocellular carcinoma.
    Yu JH; Ma S
    Exp Cell Res; 2022 Feb; 411(1):112987. PubMed ID: 34942189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential application of organoids in breast cancer research and treatment.
    Ebrahimi N; Nasr Esfahani A; Samizade S; Mansouri A; Ghanaatian M; Adelian S; Shadman Manesh V; Hamblin MR
    Hum Genet; 2022 Feb; 141(2):193-208. PubMed ID: 34713317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
    Cao W; Liu J; Wang L; Li M; Verstegen MMA; Yin Y; Ma B; Chen K; Bolkestein M; Sprengers D; van der Laan LJW; Doukas M; Kwekkeboom J; Smits R; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2019 Mar; 40(1):145-154. PubMed ID: 30289434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoids: approaches and utility in cancer research.
    Zhou B; Feng Z; Xu J; Xie J
    Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks.
    Wang Y; Takeishi K; Li Z; Cervantes-Alvarez E; Collin de l'Hortet A; Guzman-Lepe J; Cui X; Zhu J
    Organogenesis; 2017 Jul; 13(3):83-94. PubMed ID: 28548903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids.
    Ramakrishna G; Babu PE; Singh R; Trehanpati N
    Hepatol Int; 2021 Dec; 15(6):1309-1317. PubMed ID: 34596864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal, Large-Scale Propagation of Mouse Mammary Tumor Organoids.
    Wrenn ED; Moore BM; Greenwood E; McBirney M; Cheung KJ
    J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):337-350. PubMed ID: 33106923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel patient-derived preclinical models of liver cancer.
    Bresnahan E; Ramadori P; Heikenwalder M; Zender L; Lujambio A
    J Hepatol; 2020 Feb; 72(2):239-249. PubMed ID: 31954489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human liver organoids for disease modeling of fibrolamellar carcinoma.
    Narayan NJC; Requena D; Lalazar G; Ramos-Espiritu L; Ng D; Levin S; Shebl B; Wang R; Hammond WJ; Saltsman JA; Gehart H; Torbenson MS; Clevers H; LaQuaglia MP; Simon SM
    Stem Cell Reports; 2022 Aug; 17(8):1874-1888. PubMed ID: 35803261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver organoids as a primary human model to study HBV-mediated Hepatocellular carcinoma. A review.
    Sharma S; Rawal P; Kaur S; Puria R
    Exp Cell Res; 2023 Jul; 428(1):113618. PubMed ID: 37142202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer.
    De Siervi S; Turato C
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.